"Clesrovimab administered as a single dose for infants of all weights provided protection against mild, moderate, and severe ...

The investigational monoclonal antibody nipocalimab is associated with significant improvement in patients with generalized ...

A study led by Dr. Hassan Aboul-Ella (Department of Microbiology, Faculty of Veterinary Medicine, Cairo University) has been ...

As companies roll out data showing the power and improved safety profile of antibodies that target two antigens, analysts say ...

Clesrovimab (MK-1654), an Investigational RSV Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and ...

Image Credit: Nemes Laszlo/Shutterstock.com Contact stirring, however, demonstrates just one type of stress that can occur ...

"Inebilizumab is a humanized monoclonal antibody that causes targeted and sustained depletion of CD19-positive B cells, ...

Junshi Biosciences licensed the exclusive commercial rights for Toripalimab, the Shanghai-based drugmaker's monoclonal ...

Opdivo showed a 52% progression-free survival advantage over Adcetris in newly diagnosed Hodgkin’s lymphoma, according to a ...

Merck presents positive results from phase 2b/3 trial of clesrovimab, an investigational RSV preventative monoclonal antibody at IDWeek 2024: Rahway, New Jersey Saturday, October ...

Explore how mAbs are transforming disease treatment, the evolution from murine to humanized antibodies, and the impact of biosimilar antibodies on cost-effective therapies.

Learn how TA Instruments' RS-DSC enables rapid thermal stability screening of monoclonal antibody drug products.